The Institute of Cancer Research
@icr.ac.uk
The ICR is making the discoveries that defeat cancer.
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
Pinned
🚨BIG news 🚨
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
🚨The NSC has recommended PSA screening for men with BRCA1/BRCA2 variants.
Our research shows these men face higher risk of aggressive #ProstateCancer.
Screening saves lives—but we’re calling for annual tests and wider BRCA testing.
More information ⬇️
Our research shows these men face higher risk of aggressive #ProstateCancer.
Screening saves lives—but we’re calling for annual tests and wider BRCA testing.
More information ⬇️
ICR responds to announcement of prostate cancer screening for men with BRCA1 and BRCA2 gene mutations
ICR responds to announcement of prostate cancer screening for men with BRCA1 and BRCA2 gene mutations
www.icr.ac.uk
November 28, 2025 at 5:08 PM
🚨The NSC has recommended PSA screening for men with BRCA1/BRCA2 variants.
Our research shows these men face higher risk of aggressive #ProstateCancer.
Screening saves lives—but we’re calling for annual tests and wider BRCA testing.
More information ⬇️
Our research shows these men face higher risk of aggressive #ProstateCancer.
Screening saves lives—but we’re calling for annual tests and wider BRCA testing.
More information ⬇️
📺TONIGHT: Don't miss 'Cancer Detectives: Finding the Cures' at 9pm on Channel 4.
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
November 27, 2025 at 8:40 PM
📺TONIGHT: Don't miss 'Cancer Detectives: Finding the Cures' at 9pm on Channel 4.
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
🚨Watch Cancer Detectives: Finding the Cures tonight at 9pm on Channel 4.
Featuring Professor Juanita Lopez and the 5G trial – the world’s first adaptive clinical trial for #BrainCancer patients. This could accelerate new treatments for glioblastoma.
Learn more about the 5G trial ahead of the ep ⬇️
Featuring Professor Juanita Lopez and the 5G trial – the world’s first adaptive clinical trial for #BrainCancer patients. This could accelerate new treatments for glioblastoma.
Learn more about the 5G trial ahead of the ep ⬇️
World's first trial to test multiple treatments for brain cancers
A pioneering research study which will allow brain cancer patients to access drugs that are precisely targeted to their disease and swap to different treatments if needed, has launched in the UK.
www.icr.ac.uk
November 27, 2025 at 3:02 PM
🚨Watch Cancer Detectives: Finding the Cures tonight at 9pm on Channel 4.
Featuring Professor Juanita Lopez and the 5G trial – the world’s first adaptive clinical trial for #BrainCancer patients. This could accelerate new treatments for glioblastoma.
Learn more about the 5G trial ahead of the ep ⬇️
Featuring Professor Juanita Lopez and the 5G trial – the world’s first adaptive clinical trial for #BrainCancer patients. This could accelerate new treatments for glioblastoma.
Learn more about the 5G trial ahead of the ep ⬇️
Last week, we welcomed 72 sixth form students from seven local schools to Sutton for our annual Careers in Research Evening. 👋
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
November 27, 2025 at 2:03 PM
Last week, we welcomed 72 sixth form students from seven local schools to Sutton for our annual Careers in Research Evening. 👋
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
🚨BIG news 🚨
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
November 25, 2025 at 7:02 PM
🚨BIG news 🚨
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
Charity-funded research is a cornerstone of innovation in our universities – but it needs the right support to thrive.
Ahead of the #Budget, our Advocacy Manager, @ollierichards.bsky.social, shares what’s needed to keep the Charity Research Support Fund strong.
Read more ⤵️
www.icr.ac.uk/crsf-blog
Ahead of the #Budget, our Advocacy Manager, @ollierichards.bsky.social, shares what’s needed to keep the Charity Research Support Fund strong.
Read more ⤵️
www.icr.ac.uk/crsf-blog
The Charity Research Support Fund: An overlooked, and neglected, lifeline for UK science
The Charity Research Support Fund: An overlooked, and neglected, lifeline for UK science
www.icr.ac.uk
November 25, 2025 at 9:51 AM
Charity-funded research is a cornerstone of innovation in our universities – but it needs the right support to thrive.
Ahead of the #Budget, our Advocacy Manager, @ollierichards.bsky.social, shares what’s needed to keep the Charity Research Support Fund strong.
Read more ⤵️
www.icr.ac.uk/crsf-blog
Ahead of the #Budget, our Advocacy Manager, @ollierichards.bsky.social, shares what’s needed to keep the Charity Research Support Fund strong.
Read more ⤵️
www.icr.ac.uk/crsf-blog
The first men have now been invited to join the ambitious £42m TRANSFORM prostate cancer screening trial
It is co-led by six of the world’s leading #ProstateCancer researchers – including Professor Ros Eeles from the ICR.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
It is co-led by six of the world’s leading #ProstateCancer researchers – including Professor Ros Eeles from the ICR.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
First men invited to take part in most ambitious prostate cancer trial in decades
First men invited to take part in the most ambitious prostate cancer trial in decades
www.icr.ac.uk
November 21, 2025 at 12:58 PM
The first men have now been invited to join the ambitious £42m TRANSFORM prostate cancer screening trial
It is co-led by six of the world’s leading #ProstateCancer researchers – including Professor Ros Eeles from the ICR.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
It is co-led by six of the world’s leading #ProstateCancer researchers – including Professor Ros Eeles from the ICR.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
📢 Ahead of the Budget next week, we've published a paper calling for the Government to both invest in and reform the Charity Research Support Fund (CRSF) – a critical funding stream that enables vital charity-funded research in universities.
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
November 20, 2025 at 10:15 AM
📢 Ahead of the Budget next week, we've published a paper calling for the Government to both invest in and reform the Charity Research Support Fund (CRSF) – a critical funding stream that enables vital charity-funded research in universities.
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
🚨 Our scientists have been at the forefront of #ProstateCancer screening and drug development for decades – leading innovative research and international clinical trials to give every man with prostate cancer the best chance of survival with a better quality of life.
🧵⬇️
🧵⬇️
November 14, 2025 at 1:27 PM
🚨 Our scientists have been at the forefront of #ProstateCancer screening and drug development for decades – leading innovative research and international clinical trials to give every man with prostate cancer the best chance of survival with a better quality of life.
🧵⬇️
🧵⬇️
It's 25 years of the @breastcancernow.bsky.social Toby Robins Research Centre at the ICR, celebrating the pioneering research that’s transforming the outlook for people with #BreastCancer 🩷
November 13, 2025 at 2:25 PM
It's 25 years of the @breastcancernow.bsky.social Toby Robins Research Centre at the ICR, celebrating the pioneering research that’s transforming the outlook for people with #BreastCancer 🩷
Why do men tend to fare worse than women in acute myeloid leukaemia (AML)?
New research has ruled out hormone signalling as the cause – helping refine the search for biological factors that drive this difference.
A thread 🧵⬇️
New research has ruled out hormone signalling as the cause – helping refine the search for biological factors that drive this difference.
A thread 🧵⬇️
November 11, 2025 at 10:24 AM
Why do men tend to fare worse than women in acute myeloid leukaemia (AML)?
New research has ruled out hormone signalling as the cause – helping refine the search for biological factors that drive this difference.
A thread 🧵⬇️
New research has ruled out hormone signalling as the cause – helping refine the search for biological factors that drive this difference.
A thread 🧵⬇️
A pioneering clinical trial has shown that combining two existing treatments could transform outcomes for people with advanced sarcoma and melanoma in their limbs, providing hope to patients whose treatment options are currently limited.
November 7, 2025 at 9:56 AM
A pioneering clinical trial has shown that combining two existing treatments could transform outcomes for people with advanced sarcoma and melanoma in their limbs, providing hope to patients whose treatment options are currently limited.
🚨In our latest technology feature, we go behind the scenes of the Structural Chemistry Facility at the Centre for Cancer Drug Discovery to explore how mass spectrometry and nuclear magnetic resonance are driving forward the discovery of new cancer treatments.
November 6, 2025 at 9:37 AM
🚨In our latest technology feature, we go behind the scenes of the Structural Chemistry Facility at the Centre for Cancer Drug Discovery to explore how mass spectrometry and nuclear magnetic resonance are driving forward the discovery of new cancer treatments.
BRCA gene testing can identify cancer risk, but access is limited.
A new digital pathway from the ICR is expanding testing in high-risk groups by making the process more efficient and cost-effective.
In the longer term, this approach could lead to better patient outcomes.
More from us here ⬇️
A new digital pathway from the ICR is expanding testing in high-risk groups by making the process more efficient and cost-effective.
In the longer term, this approach could lead to better patient outcomes.
More from us here ⬇️
Could expanding BRCA gene testing save lives in breast and ovarian cancer?
Could expanding BRCA gene testing save lives in breast and ovarian cancer?
www.icr.ac.uk
October 28, 2025 at 9:17 AM
BRCA gene testing can identify cancer risk, but access is limited.
A new digital pathway from the ICR is expanding testing in high-risk groups by making the process more efficient and cost-effective.
In the longer term, this approach could lead to better patient outcomes.
More from us here ⬇️
A new digital pathway from the ICR is expanding testing in high-risk groups by making the process more efficient and cost-effective.
In the longer term, this approach could lead to better patient outcomes.
More from us here ⬇️
🎉 We were honoured to award Sir Bob Champion CBE with an honorary doctorate for his outstanding work in supporting research into male cancers at our graduation today.
October 27, 2025 at 7:30 PM
🎉 We were honoured to award Sir Bob Champion CBE with an honorary doctorate for his outstanding work in supporting research into male cancers at our graduation today.
Graduation Day is here! 🎓🎓🎓
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
October 27, 2025 at 4:43 PM
Graduation Day is here! 🎓🎓🎓
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
“Although drug resistance closes some doors, it can open new ones.”
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
October 23, 2025 at 9:34 AM
“Although drug resistance closes some doors, it can open new ones.”
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
📢 Interested in doing a #PhD with us?
Applications are now open for our 2025/26 fully-funded PhD studentships 🔬 🥼
Subject areas include:
✅Chemistry
✅Biology
✅Computer Science
✅Physics
⚠️ Deadline: Sunday 16 November 2025
Find out more about entry requirements, stipends, and project proposals ⤵️
Applications are now open for our 2025/26 fully-funded PhD studentships 🔬 🥼
Subject areas include:
✅Chemistry
✅Biology
✅Computer Science
✅Physics
⚠️ Deadline: Sunday 16 November 2025
Find out more about entry requirements, stipends, and project proposals ⤵️
Our PhD projects - The Institute of Cancer Research, London
Apply for our fully-funded PhD projects in subjects including chemistry, biology, computer science, and physics.
www.icr.ac.uk
October 22, 2025 at 4:04 PM
📢 Interested in doing a #PhD with us?
Applications are now open for our 2025/26 fully-funded PhD studentships 🔬 🥼
Subject areas include:
✅Chemistry
✅Biology
✅Computer Science
✅Physics
⚠️ Deadline: Sunday 16 November 2025
Find out more about entry requirements, stipends, and project proposals ⤵️
Applications are now open for our 2025/26 fully-funded PhD studentships 🔬 🥼
Subject areas include:
✅Chemistry
✅Biology
✅Computer Science
✅Physics
⚠️ Deadline: Sunday 16 November 2025
Find out more about entry requirements, stipends, and project proposals ⤵️
New global study busts the myth of a ‘cancer epidemic’ in young adults — except for #BowelCancer.
📈 ICR Researchers analysed data from 42 countries and found rising cancer rates in both younger and older adults for several types — not just the under 50s.
📈 ICR Researchers analysed data from 42 countries and found rising cancer rates in both younger and older adults for several types — not just the under 50s.
October 21, 2025 at 8:05 AM
New global study busts the myth of a ‘cancer epidemic’ in young adults — except for #BowelCancer.
📈 ICR Researchers analysed data from 42 countries and found rising cancer rates in both younger and older adults for several types — not just the under 50s.
📈 ICR Researchers analysed data from 42 countries and found rising cancer rates in both younger and older adults for several types — not just the under 50s.
📈This #WorldStatisticsDay, we’re celebrating our statisticians who apply rigorous statistical methods to turn complex data into the discoveries that defeat cancer.
October 20, 2025 at 9:21 AM
📈This #WorldStatisticsDay, we’re celebrating our statisticians who apply rigorous statistical methods to turn complex data into the discoveries that defeat cancer.
Reposted by The Institute of Cancer Research
Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers
Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks.
Head and neck cancer is the world’s sixth most common form of the disease. If it spreads or comes back after standard treatment, patients may be offered immunotherapy and platinum chemotherapy. But if this fails, there is often little else doctors can do. Continue reading...
www.theguardian.com
October 19, 2025 at 3:39 PM
Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
🚨 A new treatment is showing real promise for head & neck cancer.
#Amivantamab shrank or halted tumours in 76 per cent of patients in a new trial presented at @myesmo.bsky.social by ICR's Professor Kevin Harrington and The Royal Marsden.
#ESMO25 #CancerResearch
#Amivantamab shrank or halted tumours in 76 per cent of patients in a new trial presented at @myesmo.bsky.social by ICR's Professor Kevin Harrington and The Royal Marsden.
#ESMO25 #CancerResearch
‘Smart jab’ shows promise in treating advanced head and neck cancer
‘Smart jab’ shows promise in treating advanced head and neck cancer
www.icr.ac.uk
October 19, 2025 at 3:32 PM
🚨 A new treatment is showing real promise for head & neck cancer.
#Amivantamab shrank or halted tumours in 76 per cent of patients in a new trial presented at @myesmo.bsky.social by ICR's Professor Kevin Harrington and The Royal Marsden.
#ESMO25 #CancerResearch
#Amivantamab shrank or halted tumours in 76 per cent of patients in a new trial presented at @myesmo.bsky.social by ICR's Professor Kevin Harrington and The Royal Marsden.
#ESMO25 #CancerResearch
🚨Big news from #ESMO2025 (@myesmo.bsky.social)
A simple MRI scan before bladder cancer surgery could save lives. The BladderPath trial shows fewer delays, fewer deaths, and fewer unnecessary procedures — all from adding one scan at the start.
A simple MRI scan before bladder cancer surgery could save lives. The BladderPath trial shows fewer delays, fewer deaths, and fewer unnecessary procedures — all from adding one scan at the start.
October 17, 2025 at 3:53 PM
🚨Big news from #ESMO2025 (@myesmo.bsky.social)
A simple MRI scan before bladder cancer surgery could save lives. The BladderPath trial shows fewer delays, fewer deaths, and fewer unnecessary procedures — all from adding one scan at the start.
A simple MRI scan before bladder cancer surgery could save lives. The BladderPath trial shows fewer delays, fewer deaths, and fewer unnecessary procedures — all from adding one scan at the start.
Men with BRCA1 and BRCA2 mutations should get annual #ProstateCancer screening.
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
October 17, 2025 at 8:05 AM
Men with BRCA1 and BRCA2 mutations should get annual #ProstateCancer screening.
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
NEWS 📰: New drug combination could tackle advanced #ProstateCancer
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
New drug combination to tackle advanced prostate cancer
New drug combination to tackle advanced prostate cancer
www.icr.ac.uk
October 15, 2025 at 9:13 AM
NEWS 📰: New drug combination could tackle advanced #ProstateCancer
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️